Immutep

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In

Immutep Limited (IMM, Prima BioMed Ltd) is a biotechnology company headquarters in Australia. IMM focuses on personalised bio-therapeutic products for cancer. Its main products are eftilagimod alpha ("Efti" or " IMP321"), a soluble LAG-3Ig fusion protein, which is in clinical development for the treatment of cancer. Immutep has two other clinical candidates (IMP701 and IMP731) that are fully licensed to major pharmaceutical partners, and a fourth candidate (IMP761) which is in pre-clinical development.

Contact Details

Level 12 , 95 Pitt St SYDNEY NSW 2000
02 8315 7003
www.immutep.com

Lists and Charts

Share price

Immutep
Closing price for the last 90 trading days
View ASX Chart
Powered by Morningstar ®

Total Shareholder Return as at 02/12/24

Rank Company 1 Yr 5 Yr
664th Qualitas Real Estate Income Fund 11% 7.89%
665th Mitchell Services 11% -6.54%
666th Immutep 10.98% 5.39%
667th Fat Prophets Global Contrarian Fund 10.97% 0.77%
668th EVZ 10.96% -0.49%
View Full List
1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Company Share Transactions

06/12/24
Issued
Immutep
06/12/24
Other
Immutep
06/12/24
Issued
Immutep
Total value as at the date of the transaction
Powered by Morningstar ®

Company Activity

 NEW ROLE: F Vogl, 02 Dec 2024
NEW ROLE: Anne Anderson, Non-Executive Director 31 Jul 2024
NEW ROLE: F Triebel, Executive Director, Chief Scientific Officer 24 Nov 2020
REMUNERATION UPDATE: Pete A Meyers, Non-Executive Deputy Chairman, Non-Executive Director 13 Nov 2020
REMUNERATION UPDATE: Marc Voigt, Chief Executive Officer, Executive Director 13 Nov 2020
REMUNERATION UPDATE: Grant Chamberlain, Non-Executive Director 13 Nov 2020
REMUNERATION UPDATE: Deanne Miller, Chief Operating Officer, Company Secretary, General Counsel 13 Nov 2020
REMUNERATION UPDATE: Russell J Howard, Non-Executive Chairman, Non-Executive Director 13 Nov 2020
NEW ROLE: Tom RJ Bloomfield, Joint Company Secretary 03 Nov 2020

News Articles

Related Information

Access to our data for Immutep is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Immutep is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today

X